The North East’s first preventative small bowel cancer procedure

Advances in gastroenterology continue to improve how cancer is detected and prevented before it develops. In the North East of England, a pioneering preventative small bowel cancer procedure is offering new possibilities for patients at increased risk.

In this article, consultant gastroenterologist Dr Amit Chattree explains what the procedure involves, who may benefit, and why it represents an important step forward in early cancer prevention.

Understanding small bowel cancer

Small bowel cancer is relatively rare but can be serious, particularly when diagnosed at a later stage. The small bowel (small intestine) plays a vital role in digestion and nutrient absorption. Symptoms such as abdominal discomfort, unexplained weight loss, or anaemia are often non-specific, making early diagnosis challenging.

Certain individuals are at increased risk, including those with inherited conditions such as familial adenomatous polyposis (FAP) or chronic inflammatory conditions like Crohn’s disease. For these patients, surveillance and preventative treatment strategies are especially important.

What is the new preventative procedure?

The North East’s first preventative small bowel cancer procedure uses advanced endoscopic techniques to identify and remove abnormal or pre-cancerous tissue before cancer develops.

A specialised camera device, known as an enteroscope, allows detailed examination of areas of the small bowel that were previously difficult to access. During the same procedure, suspicious growths (polyps) can often be removed, significantly reducing future cancer risk.

Key features of the procedure

• Minimally invasive treatment with no need for major surgery.
• Typically performed under sedation.
• Combines diagnosis and treatment in a single session.
• Short recovery time, with same-day discharge in many cases.

Who can benefit from this approach?

This preventative procedure is primarily intended for patients at higher risk of developing small bowel cancer.

Suitable candidates include:

• Patients with a strong family history of gastrointestinal cancers.
• Individuals with genetic syndromes such as FAP.
• Those with long-standing inflammatory bowel disease.
• Patients with previously identified small bowel polyps.

For these groups, early intervention can significantly reduce the likelihood of cancer developing.

Why is this development significant?

The small bowel has historically been one of the most difficult parts of the digestive system to assess. Conventional imaging techniques may miss early abnormalities.

This innovation is significant because it prioritises cancer prevention rather than treatment. By detecting and removing pre-cancerous changes early, it is possible to intervene before cancer forms. Removing polyps or abnormal tissue at an early stage can also help prevent complications such as small bowel obstruction, which can occur when lesions grow large enough to narrow the intestine.

In addition, access to this specialist endoscopic procedure in the North East means patients can receive high-quality tertiary centre care within the region, without needing to travel elsewhere for treatment.

What to expect as a patient

Patients being considered for this small bowel endoscopy procedure will undergo an initial consultation to assess suitability. The procedure is typically carried out in an endoscopy unit and lasts between 30 and 60 minutes.

Following the procedure, mild bloating or discomfort may occur but usually resolves quickly. Most patients are able to return to normal activities within one to two days.

The introduction of the North East’s first preventative small bowel cancer procedure represents a meaningful advancement in early cancer detection and prevention. By offering a minimally invasive method to identify and treat pre-cancerous changes, this approach has the potential to improve outcomes for high-risk patients.